Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: A retrospective cohort study.

Gray E, Marti J, Wyatt JC, Brewster DH, Hall PS; SATURNE advisory group.

PLoS Med. 2019 Dec 31;16(12):e1003006. doi: 10.1371/journal.pmed.1003006. eCollection 2019 Dec.

2.

Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).

Menon U, Vedsted P, Zalounina Falborg A, Jensen H, Harrison S, Reguilon I, Barisic A, Bergin RJ, Brewster DH, Butler J, Brustugun OT, Bucher O, Cairnduff V, Gavin A, Grunfeld E, Harland E, Kalsi J, Knudsen AK, Lambe M, Law RJ, Lin Y, Malmberg M, Turner D, Neal RD, White V, Weller D.

BMJ Open. 2019 Nov 27;9(11):e025895. doi: 10.1136/bmjopen-2018-025895.

3.

Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study.

Wright P, Wilding S, Watson E, Downing A, Selby P, Hounsome L, Wagland R, Brewster DH, Huws D, Butcher H, Mottram R, Kearney T, Allen M, Gavin A, Glaser A.

Cancer Epidemiol. 2019 Jun;60:201-207. doi: 10.1016/j.canep.2019.04.006. Epub 2019 May 6.

4.

Declining hysterectomy prevalence and the estimated impact on uterine cancer incidence in Scotland.

Ruiz de Azua Unzurrunzaga G, Brewster DH, Wild SH, Sivalingam VN.

Cancer Epidemiol. 2019 Apr;59:227-231. doi: 10.1016/j.canep.2019.02.008. Epub 2019 Mar 2.

PMID:
30836220
5.

Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.

Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, Wagland R, Kind P, Donnelly DW, Butcher H, Catto JWF, Cross W, Mason M, Sharp L, Weller D, Velikova G, McCaughan E, Mottram R, Allen M, Kearney T, McSorley O, Huws DW, Brewster DH, McNair E, Gavin A, Glaser AW.

Lancet Oncol. 2019 Mar;20(3):436-447. doi: 10.1016/S1470-2045(18)30780-0. Epub 2019 Jan 31.

6.

Real-world evidence was feasible for estimating effectiveness of chemotherapy in breast cancer: a cohort study.

Gray E, Marti J, Brewster DH, Wyatt JC, Piaget-Rossel R, Hall PS.

J Clin Epidemiol. 2019 May;109:125-132. doi: 10.1016/j.jclinepi.2019.01.006. Epub 2019 Jan 31.

PMID:
30711490
7.

Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.

Eden M, Harrison S, Griffin M, Lambe M, Pettersson D, Gavin A, Brewster DH, Lin Y, Johannesen TB, Milne RL, Farrugia H, Nishri D, King MJ, Huws DW, Warlow J, Turner D, Earle CC, Peake M, Rashbass J.

Cancer Epidemiol. 2019 Feb;58:184-192. doi: 10.1016/j.canep.2018.10.019. Epub 2019 Jan 9.

PMID:
30639877
8.

Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).

Weller D, Menon U, Zalounina Falborg A, Jensen H, Barisic A, Knudsen AK, Bergin RJ, Brewster DH, Cairnduff V, Gavin AT, Grunfeld E, Harland E, Lambe M, Law RJ, Lin Y, Malmberg M, Turner D, Neal RD, White V, Harrison S, Reguilon I; ICBP Module 4 Working Group, Vedsted P.

BMJ Open. 2018 Nov 27;8(11):e023870. doi: 10.1136/bmjopen-2018-023870.

9.

Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.

Gray E, Marti J, Brewster DH, Wyatt JC, Hall PS; SATURNE Advisory Group.

Br J Cancer. 2018 Oct;119(7):808-814. doi: 10.1038/s41416-018-0256-x. Epub 2018 Sep 17.

10.

Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study.

Stiller CA, Botta L, Brewster DH, Ho VKY, Frezza AM, Whelan J, Casali PG, Trama A, Gatta G; EUROCARE-5 Working Group.

Cancer Epidemiol. 2018 Oct;56:146-153. doi: 10.1016/j.canep.2018.08.010. Epub 2018 Sep 1.

PMID:
30179828
11.

Perinatal risks in female cancer survivors: A population-based analysis.

van der Kooi ALF, Brewster DH, Wood R, Nowell S, Fischbacher C, van den Heuvel-Eibrink MM, Laven JSE, Wallace WHB, Anderson RA.

PLoS One. 2018 Aug 23;13(8):e0202805. doi: 10.1371/journal.pone.0202805. eCollection 2018.

12.

Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality.

Libby G, Fraser CG, Carey FA, Brewster DH, Steele RJC.

Gut. 2018 Dec;67(12):2116-2123. doi: 10.1136/gutjnl-2018-316483. Epub 2018 Jul 16.

13.

Impact of rurality on processes and outcomes in melanoma care: results from a whole-Scotland melanoma cohort in primary and secondary care.

Murchie P, Adam R, Khor WL, Raja EA, Iversen L, Brewster DH, Lee AJ.

Br J Gen Pract. 2018 Aug;68(673):e566-e575. doi: 10.3399/bjgp18X697901. Epub 2018 Jun 18.

14.

The impact of cancer on subsequent chance of pregnancy: a population-based analysis.

Anderson RA, Brewster DH, Wood R, Nowell S, Fischbacher C, Kelsey TW, Wallace WHB.

Hum Reprod. 2018 Jul 1;33(7):1281-1290. doi: 10.1093/humrep/dey216.

15.

Urinary, bowel and sexual health in older men from Northern Ireland.

Donnelly DW, Donnelly C, Kearney T, Weller D, Sharp L, Downing A, Wilding S, Wright P, Kind P, Catto JWF, Cross WR, Mason MD, McCaughan E, Wagland R, Watson E, Mottram R, Allen M, Butcher H, Hounsome L, Selby P, Huws D, Brewster DH, McNair E, Rivas C, Nayoan J, Horton M, Matheson L, Glaser AW, Gavin A.

BJU Int. 2018 Nov;122(5):845-857. doi: 10.1111/bju.14182. Epub 2018 Mar 25.

16.

Trends in incidence of thick, thin and in situ melanoma in Europe.

Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S.

Eur J Cancer. 2018 Mar;92:108-118. doi: 10.1016/j.ejca.2017.12.024. Epub 2018 Jan 31.

PMID:
29395684
17.

Pathways to diagnosis of a second primary cancer: protocol for a mixed-methods systematic review.

Kanguru L, Bikker A, Cavers D, Barnett K, Brewster DH, Weller D, Campbell C.

BMJ Open. 2017 Dec 21;7(12):e017929. doi: 10.1136/bmjopen-2017-017929.

18.

Is initial excision of cutaneous melanoma by General Practitioners (GPs) dangerous? Comparing patient outcomes following excision of melanoma by GPs or in hospital using national datasets and meta-analysis.

Murchie P, Amalraj Raja E, Brewster DH, Iversen L, Lee AJ.

Eur J Cancer. 2017 Nov;86:373-384. doi: 10.1016/j.ejca.2017.09.034. Epub 2017 Nov 5.

PMID:
29100192
19.

Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.

Lüchtenborg M, Morris EJA, Tataru D, Coupland VH, Smith A, Milne RL, Te Marvelde L, Baker D, Young J, Turner D, Nishri D, Earle C, Shack L, Gavin A, Fitzpatrick D, Donnelly C, Lin Y, Møller B, Brewster DH, Deas A, Huws DW, White C, Warlow J, Rashbass J, Peake MD.

Thorax. 2018 Apr;73(4):339-349. doi: 10.1136/thoraxjnl-2017-210362. Epub 2017 Oct 27.

20.

A cancer geography paradox? Poorer cancer outcomes with longer travelling times to healthcare facilities despite prompter diagnosis and treatment: a data-linkage study.

Turner M, Fielding S, Ong Y, Dibben C, Feng Z, Brewster DH, Black C, Lee A, Murchie P.

Br J Cancer. 2017 Jul 25;117(3):439-449. doi: 10.1038/bjc.2017.180. Epub 2017 Jun 22.

21.

Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study.

Downing A, Wright P, Wagland R, Watson E, Kearney T, Mottram R, Allen M, Cairnduff V, McSorley O, Butcher H, Hounsome L, Donnelly C, Selby P, Kind P, Cross W, Catto JW, Huws D, Brewster DH, McNair E, Matheson L, Rivas C, Nayoan J, Horton M, Corner J, Verne J, Gavin A, Glaser AW.

BMJ Open. 2016 Dec 7;6(12):e013555. doi: 10.1136/bmjopen-2016-013555.

22.

Risk of hospitalization and death following prostate biopsy in Scotland.

Brewster DH, Fischbacher CM, Nolan J, Nowell S, Redpath D, Nabi G.

Public Health. 2017 Jan;142:102-110. doi: 10.1016/j.puhe.2016.10.006. Epub 2016 Oct 31.

23.

Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study.

Wu H, Walker J, Damhuis RA, Brewster DH, Wild SH; Scottish Diabetes Research Network Epidemiology Group.

Lung Cancer. 2016 Sep;99:194-9. doi: 10.1016/j.lungcan.2016.07.020. Epub 2016 Jul 20.

PMID:
27565939
24.

Interval cancers in a national colorectal cancer screening programme.

Steele RJ, Stanners G, Lang J, Brewster DH, Carey FA, Fraser CG.

United European Gastroenterol J. 2016 Aug;4(4):587-94. doi: 10.1177/2050640615624294. Epub 2016 Jan 6.

25.

Response to Crocetti et al.

Derakhshan MH, Arnold M, Brewster DH, Going JJ, Mitchell DR, Forman D, McColl KE.

Am J Gastroenterol. 2016 Aug;111(8):1202-3. doi: 10.1038/ajg.2016.228. No abstract available.

PMID:
27481422
26.

Completeness of primary intracranial tumour recording in the Scottish Cancer Registry 2011-2012.

Morling JR, Grant R, Brewster DH.

Public Health. 2016 Nov;140:278-281. doi: 10.1016/j.puhe.2016.05.024. Epub 2016 Jun 28. No abstract available.

PMID:
27370699
27.

Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects.

Derakhshan MH, Arnold M, Brewster DH, Going JJ, Mitchell DR, Forman D, McColl KE.

Am J Gastroenterol. 2016 Feb;111(2):228-39. doi: 10.1038/ajg.2015.405. Epub 2016 Jan 12.

PMID:
26753891
28.

Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.

De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2254-2268. doi: 10.1016/j.ejca.2015.08.003. Epub 2015 Sep 26.

PMID:
26421827
29.

Seasonal variation in diagnosis of invasive cutaneous melanoma in Eastern England and Scotland.

Walter FM, Abel GA, Lyratzopoulos G, Melia J, Greenberg D, Brewster DH, Butler H, Corrie PG, Campbell C.

Cancer Epidemiol. 2015 Aug;39(4):554-61. doi: 10.1016/j.canep.2015.06.006. Epub 2015 Jul 2.

30.

Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.

Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Antoni S, Soerjomataram I, Forman D.

Int J Cancer. 2015 Nov 1;137(9):2060-71. doi: 10.1002/ijc.29670.

31.

Risk of oesophageal cancer among patients previously hospitalised with eating disorder.

Brewster DH, Nowell SL, Clark DN.

Cancer Epidemiol. 2015 Jun;39(3):313-20. doi: 10.1016/j.canep.2015.02.009. Epub 2015 Mar 11.

32.

Effect of longer health service provider delays on stage at diagnosis and mortality in symptomatic breast cancer.

Murchie P, Raja EA, Lee AJ, Brewster DH, Campbell NC, Gray NM, Ritchie LD, Robertson R, Samuel L.

Breast. 2015 Jun;24(3):248-55. doi: 10.1016/j.breast.2015.02.027. Epub 2015 Mar 7.

PMID:
25753211
33.

Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project.

Stiller CA, Trama A, Brewster DH, Verne J, Bouchardy C, Navarro C, Chirlaque MD, Marcos-Gragera R, Visser O, Serraino D, Weiderpass E, Dei Tos AP, Ascoli V; RARECARE Working Group.

Cancer Epidemiol. 2014 Dec;38(6):670-8. doi: 10.1016/j.canep.2014.09.009. Epub 2014 Oct 22.

PMID:
25454979
34.

Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer.

Libby G, Brewster DH, Steele RJ.

Br J Surg. 2014 Nov;101(12):1607-15. doi: 10.1002/bjs.9613. Epub 2014 Sep 13.

PMID:
25219923
35.

Time from first presentation in primary care to treatment of symptomatic colorectal cancer: effect on disease stage and survival.

Murchie P, Raja EA, Brewster DH, Campbell NC, Ritchie LD, Robertson R, Samuel L, Gray N, Lee AJ.

Br J Cancer. 2014 Jul 29;111(3):461-9. doi: 10.1038/bjc.2014.352. Epub 2014 Jul 3.

36.

Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.

Cuschieri K, Brewster DH, Graham C, Nicoll S, Williams AR, Murray GI, Millan D, Johannessen I, Hardie A, Cubie HA.

Int J Cancer. 2014 Dec 1;135(11):2721-6. doi: 10.1002/ijc.28902. Epub 2014 Apr 29.

37.

Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.

Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA.

Cancer Epidemiol. 2014 Jun;38(3):227-34. doi: 10.1016/j.canep.2014.03.010. Epub 2014 Apr 13.

PMID:
24726751
38.

Policy for home or hospice as the preferred place of death from cancer: Scottish Health and Ethnicity Linkage Study population cohort shows challenges across all ethnic groups in Scotland.

Sharpe KH, Cezard G, Bansal N, Bhopal RS, Brewster DH.

BMJ Support Palliat Care. 2015 Dec;5(4):443-51. doi: 10.1136/bmjspcare-2013-000485. Epub 2013 Nov 19.

PMID:
24644191
39.

Association between socioeconomic factors and cancer risk: a population cohort study in Scotland (1991-2006).

Sharpe KH, McMahon AD, Raab GM, Brewster DH, Conway DI.

PLoS One. 2014 Feb 27;9(2):e89513. doi: 10.1371/journal.pone.0089513. eCollection 2014.

40.

Introduction.

Forman D, Brewster DH, Kohler B, Piñeros M.

IARC Sci Publ. 2014;(164 Pt 1):23-36. No abstract available.

PMID:
27220124
41.

Subsequent hospitalisation experience of 5-year survivors of childhood, adolescent, and young adult cancer in Scotland: a population based, retrospective cohort study.

Brewster DH, Clark D, Hopkins L, Bauer J, Wild SH, Edgar AB, Wallace WH.

Br J Cancer. 2014 Mar 4;110(5):1342-50. doi: 10.1038/bjc.2013.788. Epub 2013 Dec 24.

42.

Beware using secular trends in deaths to judge effectiveness of breast screening.

Brewster DH, Bhatti LA, Thomson CS, Cameron DA, Dewar JA.

BMJ. 2013 Jul 10;347:f4335. doi: 10.1136/bmj.f4335. No abstract available.

PMID:
23842431
43.

Subsequent mortality experience in five-year survivors of childhood, adolescent and young adult cancer in Scotland: a population based, retrospective cohort study.

Brewster DH, Clark D, Hopkins L, Bauer J, Wild SH, Edgar AB, Hamish Wallace W.

Eur J Cancer. 2013 Oct;49(15):3274-83. doi: 10.1016/j.ejca.2013.05.004. Epub 2013 Jun 8.

PMID:
23756361
44.

Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001-2007.

Walker JJ, Brewster DH, Colhoun HM, Fischbacher CM, Leese GP, Lindsay RS, McKnight JA, Philip S, Sattar N, Stockton DL, Wild SH; Scottish Diabetes Research Network (SDRN) Epidemiology Group.

Diabetologia. 2013 Aug;56(8):1712-5. doi: 10.1007/s00125-013-2937-6. Epub 2013 May 10.

45.

Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007).

Walker JJ, Brewster DH, Colhoun HM, Fischbacher CM, Lindsay RS, Wild SH; Scottish Diabetes Research Network (SDRN) Epidemiology Group.

Diabetologia. 2013 Jul;56(7):1531-41. doi: 10.1007/s00125-013-2917-x. Epub 2013 Apr 27.

PMID:
23624531
46.

Risk of cancer following primary total hip replacement or primary resurfacing arthroplasty of the hip: a retrospective cohort study in Scotland.

Brewster DH, Stockton DL, Reekie A, Ashcroft GP, Howie CR, Porter DE, Black RJ.

Br J Cancer. 2013 May 14;108(9):1883-90. doi: 10.1038/bjc.2013.129. Epub 2013 Apr 2.

47.

Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data.

Dunbar JK, Dillon J, Garden OJ, Brewster DH.

HPB (Oxford). 2013 Apr;15(4):279-85. doi: 10.1111/j.1477-2574.2012.00567.x. Epub 2012 Oct 15.

48.

Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990.

Verhoeven RH, Janssen-Heijnen ML, Saum KU, Zanetti R, Caldarella A, Holleczek B, Brewster DH, Hakulinen T, Horenblas S, Brenner H, Gondos A; EUNICE Survival Working Group.

Eur J Cancer. 2013 Apr;49(6):1414-21. doi: 10.1016/j.ejca.2012.10.029. Epub 2012 Dec 8.

PMID:
23231984
49.

Testicular cancer in Europe and the USA: survival still rising among older patients.

Verhoeven RH, Gondos A, Janssen-Heijnen ML, Saum KU, Brewster DH, Holleczek B, Crocetti E, Rosso S, Hakulinen T, Aareleid T, Brenner H; EUNICE Survival Working Group.

Ann Oncol. 2013 Feb;24(2):508-13. doi: 10.1093/annonc/mds460. Epub 2012 Oct 30.

50.

Does the 'Scottish effect' apply to all ethnic groups? All-cancer, lung, colorectal, breast and prostate cancer in the Scottish Health and Ethnicity Linkage Cohort Study.

Bhopal RS, Bansal N, Steiner M, Brewster DH; Scottish Health and Ethnicity Linkage Study.

BMJ Open. 2012 Sep 25;2(5). pii: e001957. doi: 10.1136/bmjopen-2012-001957. Print 2012.

Supplemental Content

Loading ...
Support Center